Eaton Vance Management’s Evolent Health EVH Stock Holding History

Eaton Vance Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3M	Hold	83,452	–	–	﹤0.01%	922
2022 Q2	$2.56M	Sell	83,452 -1	-0%	-$29	﹤0.01%	1004
2022 Q1	$2.7M	Buy	83,453 +1	+0%	+$26	﹤0.01%	1087
2021 Q4	$2.31M	Hold	83,452	–	–	﹤0.01%	994
2021 Q3	$2.59M	Hold	83,452	–	–	﹤0.01%	879
2021 Q2	$1.76M	Sell	83,452 -312	-0.4%	-$6.25K	﹤0.01%	1043
2021 Q1	$1.69M	Buy	83,764 +13,042	+18%	+$248K	﹤0.01%	1013
2020 Q4	$1.13M	Buy	+70,722	New	+$935K	﹤0.01%	1051
2020 Q1	–	Sell	-100,000	Closed	-$905K	–	1319
2019 Q4	$905K	Hold	100,000	–	–	﹤0.01%	1017
2019 Q3	$719K	Hold	100,000	–	–	﹤0.01%	1046
2019 Q2	$795K	Hold	100,000	–	–	﹤0.01%	1017
2019 Q1	$1.26M	Hold	100,000	–	–	﹤0.01%	864
2018 Q4	$2M	Hold	100,000	–	–	0.01%	719
2018 Q3	$2.84M	Buy	+100,000	New	+$2.39M	0.01%	670

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Eaton Vance Management's EVH Position: Q3 2022 in Review

Eaton Vance Management held its Evolent Health (EVH) position steady in Q3 2022 at 83,452 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Eaton Vance Management first reported a position in EVH in Q3 2018 and has held it in 14 quarters since. 251 funds tracked by Wall St. Rank hold EVH as of Q3 2022.

Eaton Vance Management held 83,452 shares of Evolent Health worth $3M as of Q3 2022.
Eaton Vance Management left its Evolent Health share count unchanged in Q3 2022.
Evolent Health made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #922 holding.
Eaton Vance Management first reported a position in Evolent Health in Q3 2018 and has held it in 14 quarters since.
251 funds tracked by Wall St. Rank held Evolent Health as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.